STOCK TITAN

[Form 4] MicroStrategy Incorporated 8.00% Series A Perpetual Strike Preferred Stock Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

TriMas Corp. (TRS) Form 144 filing discloses a proposed sale of 63,965 common shares—about 0.16 % of the 40.64 M shares outstanding—valued at roughly $2.24 M. The seller intends to execute the trade through Fidelity Brokerage Services on Nasdaq around 29 Jul 2025. All shares were acquired in 2021 via stock-option exercises and restricted-stock vesting; no prior sales were reported in the last three months. Form 144 is a notice, not an executed sale, but it signals potential insider liquidity activity. Given the small percentage of total shares, the transaction should have limited market impact unless accompanied by further disposals.

La comunicazione del modulo 144 di TriMas Corp. (TRS) rivela una proposta di vendita di 63.965 azioni ordinarie—circa lo 0,16% delle 40,64 milioni di azioni in circolazione—per un valore approssimativo di 2,24 milioni di dollari. Il venditore intende effettuare la transazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 attraverso l'esercizio di opzioni azionarie e la maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il modulo 144 è un avviso, non una vendita eseguita, ma indica una possibile attività di liquidità da parte di insider. Considerata la piccola percentuale del totale azionario, la transazione dovrebbe avere un impatto di mercato limitato a meno che non vengano effettuate ulteriori cessioni.

La presentación del Formulario 144 de TriMas Corp. (TRS) revela una propuesta de venta de 63,965 acciones comunes—aproximadamente el 0,16% de las 40,64 millones de acciones en circulación—valoradas en alrededor de 2,24 millones de dólares. El vendedor planea ejecutar la operación a través de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidación de acciones restringidas; no se reportaron ventas previas en los últimos tres meses. El Formulario 144 es un aviso, no una venta realizada, pero señala una posible actividad de liquidez interna. Dada la pequeña proporción del total de acciones, la transacción debería tener un impacto limitado en el mercado, a menos que se acompañe de disposiciones adicionales.

TriMas Corp. (TRS)의 Form 144 제출은 약 0.16%에 해당하는 63,965주 보통주 매각 제안을 공개하며, 이는 총 4,064만 주 중 약 224만 달러 상당입니다. 매도자는 2025년 7월 29일경 나스닥의 Fidelity Brokerage Services를 통해 거래를 실행할 예정입니다. 모든 주식은 2021년에 주식 옵션 행사와 제한 주식 권리 확정을 통해 취득되었으며, 최근 3개월 내에 이전 매도 내역은 보고되지 않았습니다. Form 144는 실행된 매도가 아닌 통지서이지만, 내부자 유동성 활동 가능성을 나타냅니다. 전체 주식 중 비중이 적어 추가 매도가 없으면 시장에 미치는 영향은 제한적일 것으로 보입니다.

Le dépôt du formulaire 144 de TriMas Corp. (TRS) révèle une proposition de vente de 63 965 actions ordinaires—environ 0,16 % des 40,64 millions d’actions en circulation—d’une valeur d’environ 2,24 millions de dollars. Le vendeur prévoit d’exécuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont été acquises en 2021 par l’exercice d’options d’achat d’actions et la levée de restrictions sur des actions; aucune vente antérieure n’a été signalée au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente réalisée, mais indique une possible activité de liquidité interne. Étant donné la faible proportion du total des actions, la transaction devrait avoir un impact limité sur le marché sauf en cas de cessions supplémentaires.

Die Form 144-Meldung von TriMas Corp. (TRS) offenbart einen geplanten Verkauf von 63.965 Stammaktien—etwa 0,16 % der 40,64 Mio. ausstehenden Aktien—im Wert von rund 2,24 Mio. USD. Der Verkäufer beabsichtigt, den Handel über Fidelity Brokerage Services an der Nasdaq etwa am 29. Juli 2025 durchzuführen. Alle Aktien wurden 2021 durch Ausübung von Aktienoptionen und Vesting von Restricted Stocks erworben; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Das Formular 144 ist eine Mitteilung, kein ausgeführter Verkauf, signalisiert jedoch potenzielle Insider-Liquiditätsaktivitäten. Aufgrund des geringen Anteils an den Gesamtaktien sollte die Transaktion begrenzte Auswirkungen auf den Markt haben, sofern keine weiteren Verkäufe folgen.

Positive
  • Sale equals only 0.16 % of shares outstanding, implying minimal dilution or supply pressure.
  • No other insider sales reported in the prior 3 months, limiting aggregation concerns under Rule 144(e).
Negative
  • Insider plans to liquidate $2.24 M of stock, which can be perceived as a confidence signal worth monitoring.

Insights

TL;DR: Modest insider sale (~0.16% of float); unlikely to move TRS shares materially.

Form 144 filings highlight insider intent rather than completed trades. Here, 63.9 k shares worth $2.24 M are slated for sale—insignificant versus TriMas’ 40.6 M shares outstanding and typical daily volume. The stock was acquired through routine equity-comp programs in 2021, suggesting profit-taking rather than deterioration in fundamentals. Absence of other recent sales reduces aggregation risk under Rule 144(e). Overall, I view the filing as neutral; investors should monitor additional filings to gauge broader insider sentiment.

La comunicazione del modulo 144 di TriMas Corp. (TRS) rivela una proposta di vendita di 63.965 azioni ordinarie—circa lo 0,16% delle 40,64 milioni di azioni in circolazione—per un valore approssimativo di 2,24 milioni di dollari. Il venditore intende effettuare la transazione tramite Fidelity Brokerage Services sul Nasdaq intorno al 29 luglio 2025. Tutte le azioni sono state acquisite nel 2021 attraverso l'esercizio di opzioni azionarie e la maturazione di azioni vincolate; non sono state segnalate vendite precedenti negli ultimi tre mesi. Il modulo 144 è un avviso, non una vendita eseguita, ma indica una possibile attività di liquidità da parte di insider. Considerata la piccola percentuale del totale azionario, la transazione dovrebbe avere un impatto di mercato limitato a meno che non vengano effettuate ulteriori cessioni.

La presentación del Formulario 144 de TriMas Corp. (TRS) revela una propuesta de venta de 63,965 acciones comunes—aproximadamente el 0,16% de las 40,64 millones de acciones en circulación—valoradas en alrededor de 2,24 millones de dólares. El vendedor planea ejecutar la operación a través de Fidelity Brokerage Services en Nasdaq alrededor del 29 de julio de 2025. Todas las acciones fueron adquiridas en 2021 mediante el ejercicio de opciones sobre acciones y la consolidación de acciones restringidas; no se reportaron ventas previas en los últimos tres meses. El Formulario 144 es un aviso, no una venta realizada, pero señala una posible actividad de liquidez interna. Dada la pequeña proporción del total de acciones, la transacción debería tener un impacto limitado en el mercado, a menos que se acompañe de disposiciones adicionales.

TriMas Corp. (TRS)의 Form 144 제출은 약 0.16%에 해당하는 63,965주 보통주 매각 제안을 공개하며, 이는 총 4,064만 주 중 약 224만 달러 상당입니다. 매도자는 2025년 7월 29일경 나스닥의 Fidelity Brokerage Services를 통해 거래를 실행할 예정입니다. 모든 주식은 2021년에 주식 옵션 행사와 제한 주식 권리 확정을 통해 취득되었으며, 최근 3개월 내에 이전 매도 내역은 보고되지 않았습니다. Form 144는 실행된 매도가 아닌 통지서이지만, 내부자 유동성 활동 가능성을 나타냅니다. 전체 주식 중 비중이 적어 추가 매도가 없으면 시장에 미치는 영향은 제한적일 것으로 보입니다.

Le dépôt du formulaire 144 de TriMas Corp. (TRS) révèle une proposition de vente de 63 965 actions ordinaires—environ 0,16 % des 40,64 millions d’actions en circulation—d’une valeur d’environ 2,24 millions de dollars. Le vendeur prévoit d’exécuter la transaction via Fidelity Brokerage Services sur le Nasdaq aux alentours du 29 juillet 2025. Toutes les actions ont été acquises en 2021 par l’exercice d’options d’achat d’actions et la levée de restrictions sur des actions; aucune vente antérieure n’a été signalée au cours des trois derniers mois. Le formulaire 144 est un avis, non une vente réalisée, mais indique une possible activité de liquidité interne. Étant donné la faible proportion du total des actions, la transaction devrait avoir un impact limité sur le marché sauf en cas de cessions supplémentaires.

Die Form 144-Meldung von TriMas Corp. (TRS) offenbart einen geplanten Verkauf von 63.965 Stammaktien—etwa 0,16 % der 40,64 Mio. ausstehenden Aktien—im Wert von rund 2,24 Mio. USD. Der Verkäufer beabsichtigt, den Handel über Fidelity Brokerage Services an der Nasdaq etwa am 29. Juli 2025 durchzuführen. Alle Aktien wurden 2021 durch Ausübung von Aktienoptionen und Vesting von Restricted Stocks erworben; in den letzten drei Monaten wurden keine vorherigen Verkäufe gemeldet. Das Formular 144 ist eine Mitteilung, kein ausgeführter Verkauf, signalisiert jedoch potenzielle Insider-Liquiditätsaktivitäten. Aufgrund des geringen Anteils an den Gesamtaktien sollte die Transaktion begrenzte Auswirkungen auf den Markt haben, sofern keine weiteren Verkäufe folgen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Le Phong

(Last) (First) (Middle)
C/O MICROSTRATEGY INCORPORATED
1850 TOWERS CRESCENT PLAZA

(Street)
TYSONS CORNER VA 22182

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MICROSTRATEGY Inc [ MSTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Series A Perpetual Stretch Preferred Stock 07/29/2025 P 5,500 A $90(1) 5,500 D
Series A Perpetual Stride Preferred Stock 4,500 D
Series A Perpetual Strife Preferred Stock 6,000 D
Class A Common Stock 16,390 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares purchased through a directed share program in connection with the underwritten public offering of MicroStrategy Incorporated d/b/a Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock. These shares were purchased at the public offering price of $90.00 per share.
/s/ Allein Sabel, Attorney-in-Fact 07/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many TriMas (TRS) shares are being registered for sale?

63,965 common shares are listed in the Form 144 notice.

What is the market value of the proposed TRS share sale?

The aggregate market value is approximately $2.24 million.

When is the planned sale date for the TRS shares?

The filing cites an approximate sale date of 07/29/2025.

How large is the sale relative to TriMas’ shares outstanding?

The block represents about 0.16 % of the 40.64 million shares outstanding.

What exchange will the TRS shares be sold on?

The shares are slated for sale on the NASDAQ through Fidelity Brokerage Services.
MicroStrategy

NASDAQ:STRK

STRK Rankings

STRK Latest News

STRK Latest SEC Filings

STRK Stock Data

7.30M
0.88%
Software - Application
Finance Services
Link
United States
TYSONS CORNER